SCHEMBL5859593

SCHEMBL5859593

COc1cccc(C(CCCCCCCCCCC(O)C(=O)O)(c2ccccc2)c2ccccc2)c1OC

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 11/20 0.40
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
USP2 O75604 1/20 0.35
GPR84 Q9NQS5 3/20 0.35
FFAR1 O14842 1/20 0.35
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5859589 0.89 KIF11 (0.43) KIF11GPR84FFAR1KMT2AMEN1
SCHEMBL7541639 0.81 KIF11 (0.40) KIF11NPC1RAB9A
SCHEMBL7147418 0.79 CNR1 (0.40) CNR1CNR2
SCHEMBL7144172 0.79 CNR1 (0.40) CNR1CNR2
SCHEMBL15212062 0.77 KIF11 (0.40) KIF11CNR1CNR2NPC1RAB9A
SCHEMBL6855010 0.77 L3MBTL1 (0.39) KIF11CNR1CNR2KMT2ANPC1
SCHEMBL15212175 0.75 NFE2L2 (0.39) KIF11CNR1CNR2KMT2ANPC1
SCHEMBL5133757 0.74 NFE2L2 (0.40) KMT2ANPC1RAB9AMEN1
SCHEMBL8457737 0.73 KMT2A (0.42) USP2KMT2ANPC1RAB9AMEN1
SCHEMBL7144402 0.72 MEN1 (0.42) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348524-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2023-11-02 US disclosed
US-20230089442-A1 TECHNOLOGIES USEFUL FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2023-03-23 US disclosed
US-11608355-B2 Technologies for oligonucleotide preparation WAVE LIFE SCIENCES LTD. (SG) 2023-03-21 US disclosed
EP-3941924-A1 TECHNOLOGIES USEFUL FOR OLIGONUCLEOTIDE PREPARATION Wave Life Sciences Ltd. (SG) 2022-01-26 EP disclosed
CN-113748116-A Techniques useful for oligonucleotide preparation 波涛生命科学有限公司 2021-12-03 CN disclosed
WO-2020191252-A1 TECHNOLOGIES USEFUL FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2020-09-24 WO disclosed
EP-3684755-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION Wave Life Sciences Ltd. (SG) 2020-07-29 EP disclosed
US-20200231620-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2020-07-23 US disclosed
CN-111108096-A Oligonucleotide preparation technology 波涛生命科学有限公司 2020-05-05 CN disclosed
WO-2019055951-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2019-03-21 WO disclosed
US-7135564-B1 Reusable solid support for oligonucleotide synthesis UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2006-11-14 US disclosed
EP-1091972-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2001-04-18 EP disclosed
WO-2000001711-A1 REUSABLE SOLID SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2000-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11608355-B2 Technologies for oligonucleotide preparation POLRMT, DCLRE1B, RNGTT KIF11 185/4885CNR1 4773/4885CNR2 4829/4885
US-20200231620-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION POLRMT, DCLRE1B, RNGTT KIF11 185/4885CNR1 4773/4885CNR2 4829/4885
US-20230089442-A1 TECHNOLOGIES USEFUL FOR OLIGONUCLEOTIDE PREPARATION POLRMT, DCLRE1B, POLM KIF11 385/4885CNR1 4722/4885CNR2 4820/4885
US-20230348524-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION POLRMT, DCLRE1B, RNGTT KIF11 185/4885CNR1 4773/4885CNR2 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.